Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users

QR Code

Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users

Background: Detectable HCV-specific cellular immune responses in HCV antibody and RNA negative people who inject drugs (PWID) raise the question of whether some are resistant to HCV infection. Immune responses from people who have been exposed to hepatitis C virus (HCV) and remain anti-HCV negative...

Full description

Bibliographic Details
Main Authors:	Flynn, J., Sacks Davis, R., Higgs, Peter, Aitken, C., Moneer, S., Suppiah, V., Tracy, L., Ffrench, R., Bowden, S., Drummer, H., George, J., Bharadwaj, M., Hellard, M.
Format:	Journal Article
Published:	Kowsar 2014
Subjects:	Drug Users Cohort Studies Hepatitis C
Online Access:	http://hdl.handle.net/20.500.11937/28209

Similar Items

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin
by: Sadeq, Refat, et al.
Published: (2013)

Cohort profile: the Hepatitis C Virus (HCV) Research UK clinical database and biobank
by: McLauchlan, John, et al.
Published: (2017)

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
by: Yunihastuti, E., et al.
Published: (2011)

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy
by: Lee, S., et al.
Published: (2014)

Experimental design of a novel target to isolate HCV monoclonal antibodies
by: Brice, Sophie
Published: (2014)

Biodynamics of HCV infection in haemodialysis patients in Pahang
by: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Published: (2011)

Biodynamics of HCV infection in haemodialysis patients in Pahang
by: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Published: (2010)

Increased proportions of dendritic cells and recovery of IFNγ responses in HIV/HCV co-infected patients receiving ART
by: Saraswati, H., et al.
Published: (2015)

HCV genotypes in haemodialysis units: a preliminary study
by: Hamzah, Hairul Aini, et al.
Published: (2008)

HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin
by: Trinder, D., et al.
Published: (2008)

Hepatitis C virus (HCV) diagnosis via microfluidics
by: Narayanamurthy, Vigneswaran, et al.
Published: (2021)

Immune responses to hepatitis C virus (HCV): investigation of the role of L-ficolin and anti-E1E2
by: Hamed, Mohamed R.
Published: (2009)

Assessment of Cox2 and CMV in patients with chronic HCV infection
by: F. Hassan, Heba, et al.
Published: (2017)

Development of ELISA method for primary detection of HCV using core antigen
by: Nourollahi, Shirin, et al.
Published: (2011)

The role of blood transfusion in HCV infection: a study testing Ab: RNA & genotype
by: Waqar A. Al-Kubaisy,
Published: (2011)

Characterization of occult hepatitis c virus (hcv) infection among hemodialysis patient
by: Abdul Rahman, Siti Nurul Fazlin, et al.
Published: (2017)

Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-a and ribavirin therapy?
by: Lee, S., et al.
Published: (2010)

Establishment of simultaneous detection and quantitation of HCV-RNA by third generation intercalating dye real-time PCR
by: M. Saleh Habil, Akrahm, et al.
Published: (2018)

Identification of residues involved in NS2 homodimerization and elucidation of their impact on the HCV life cycle
by: Gorzin, A., et al.
Published: (2012)

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
by: Khera, Tanvi, et al.
Published: (2017)

The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia
by: Butler, K., et al.
Published: (2015)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

In-house semi-nested reverse transcription polymerase chain reaction for the detection of HCV-RNA in serum with low viral load
by: Hamzah, Hairul Aini, et al.
Published: (2013)

Seroprevalence study of HCV Genotypes in two tertiary hospital and its association with risk factors and current management practice
by: Hasmoni, Mohamed Hadzri, et al.
Published: (2009)

Sensitivity assay of semi-nested reverse-transcription polymerase chain reaction in detecting HCV-RNA from chronic renal disease patient
by: Hamzah, Hairul Aini, et al.
Published: (2011)

Sentivity assay of semi-nested reverse-transcription polymerase chain reaction in detecting HCV-RNA from chronic renal disease patient
by: Hamzah, Hairul Aini, et al.
Published: (2011)

Development of HCV genotyping protocol based on high resolution melting analysis real-time PCR: a pilot study
by: Hamzah, Hairul Aini
Published: (2017)

A study of the natural history of hepatitis C infection within a geographically determined population (Trent HCV study)
by: Lawson, Adam
Published: (2012)

Comparative investigation of bagging enhanced machine learning for early detection of HCV infections using class imbalance technique with feature selection
by: Tusher, Ekramul Haque, et al.
Published: (2025)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice
by: Vercauteren, Koen, et al.
Published: (2016)

Increased proportion of the CD56bright NK cell subset in patients chronically infected with Hepatitis C Virus (HCV) receiving interferon-a and ribavirin therapy
by: Lee, S., et al.
Published: (2010)

Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study
by: Aspinall, E., et al.
Published: (2014)

Production of Hepatitis B Viral Antigens and Antibodies using Phage Display Technology for the Development of a Diagnostic Test
by: Tan, Geok Hun
Published: (2006)

High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
by: Sacks-Davis, R., et al.
Published: (2013)

Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers
by: Hudu Abdullahi, Shuaibu
Published: (2017)

How “Hidden” Are Unobserved Networks Among People Who Inject Drugs?
by: Higgs, Peter, et al.
Published: (2015)

Development of a bio-nanogate-based electrochemical immunosensing strategy for the detection of anti-hepatitis B surface antigen antibody
by: Othman, Noor Syamila
Published: (2022)

Establishing the Melbourne injecting drug user cohort study (MIX): rationale, methods, and baseline and twelve-month follow-up results
by: Horyniak, D., et al.
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a8p0aufv59d1bk45rdsie568sg